These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22073206)

  • 61. Antizyme inhibitor 1: a potential carcinogenic molecule.
    Qiu S; Liu J; Xing F
    Cancer Sci; 2017 Feb; 108(2):163-169. PubMed ID: 27870265
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trypanosoma brucei brucei: characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine.
    Li F; Hua SB; Wang CC; Gottesdiener KM
    Exp Parasitol; 1998 Mar; 88(3):255-7. PubMed ID: 9562432
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mechanisms of protein degradation: an odyssey with ODC.
    Kahana C; Asher G; Shaul Y
    Cell Cycle; 2005 Nov; 4(11):1461-4. PubMed ID: 16205122
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Conformational changes in ornithine decarboxylase enable recognition by antizyme.
    Mitchell JL; Chen HJ
    Biochim Biophys Acta; 1990 Jan; 1037(1):115-21. PubMed ID: 2104755
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Turnover of trypanosomal ornithine decarboxylases.
    Persson L; Jeppsson A; Nasizadeh S
    Biochem Soc Trans; 2003 Apr; 31(2):411-4. PubMed ID: 12653649
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The translation initiation site of recombinant Trypanosoma brucei ornithine decarboxylase varies with different promoters.
    Kuntz DA; Phillips MA; Moore TD; Craig SP; Bass KE; Wang CC
    Mol Biochem Parasitol; 1992 Oct; 55(1-2):95-104. PubMed ID: 1435879
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of mutations at active site residues on the activity of ornithine decarboxylase and its inhibition by active site-directed irreversible inhibitors.
    Coleman CS; Stanley BA; Pegg AE
    J Biol Chem; 1993 Nov; 268(33):24572-9. PubMed ID: 8227016
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acidic residues important for substrate binding and cofactor reactivity in eukaryotic ornithine decarboxylase identified by alanine scanning mutagenesis.
    Osterman AL; Kinch LN; Grishin NV; Phillips MA
    J Biol Chem; 1995 May; 270(20):11797-802. PubMed ID: 7744828
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ornithine decarboxylase-antizyme is rapidly degraded through a mechanism that requires functional ubiquitin-dependent proteolytic activity.
    Gandre S; Bercovich Z; Kahana C
    Eur J Biochem; 2002 Feb; 269(4):1316-22. PubMed ID: 11856366
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Procyclic Trypanosoma brucei cell lines deficient in ornithine decarboxylase activity.
    Li F; Hua SB; Wang CC; Gottesdiener KM
    Mol Biochem Parasitol; 1996 Jun; 78(1-2):227-36. PubMed ID: 8813692
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization and sequence analysis of the human ornithine decarboxylase gene.
    Fitzgerald MC; Flanagan MA
    DNA; 1989 Nov; 8(9):623-34. PubMed ID: 2693021
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Induction of epithelial differentiation and DNA demethylation in hamster malignant oral keratinocyte by ornithine decarboxylase antizyme.
    Tsuji T; Usui S; Aida T; Tachikawa T; Hu GF; Sasaki A; Matsumura T; Todd R; Wong DT
    Oncogene; 2001 Jan; 20(1):24-33. PubMed ID: 11244502
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function.
    Albeck S; Dym O; Unger T; Snapir Z; Bercovich Z; Kahana C
    Protein Sci; 2008 May; 17(5):793-802. PubMed ID: 18369191
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of the genes coding for ornithine decarboxylase and its regulatory protein antizyme in the developing rat brain.
    Pujic Z; Matsumoto I; Wilce PA
    Dev Neurosci; 1995; 17(5-6):286-91. PubMed ID: 8829917
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei.
    Bellofatto V; Fairlamb AH; Henderson GB; Cross GA
    Mol Biochem Parasitol; 1987 Oct; 25(3):227-38. PubMed ID: 3122042
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Yeast antizyme mediates degradation of yeast ornithine decarboxylase by yeast but not by mammalian proteasome: new insights on yeast antizyme.
    Porat Z; Landau G; Bercovich Z; Krutauz D; Glickman M; Kahana C
    J Biol Chem; 2008 Feb; 283(8):4528-34. PubMed ID: 18089576
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pyruvate kinase of Trypanosoma brucei: overexpression, purification, and functional characterization of wild-type and mutated enzyme.
    Ernest I; Callens M; Uttaro AD; Chevalier N; Opperdoes FR; Muirhead H; Michels PA
    Protein Expr Purif; 1998 Aug; 13(3):373-82. PubMed ID: 9693062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of the Entamoeba histolytica ornithine decarboxylase-like enzyme.
    Jhingran A; Padmanabhan PK; Singh S; Anamika K; Bakre AA; Bhattacharya S; Bhattacharya A; Srinivasan N; Madhubala R
    PLoS Negl Trop Dis; 2008 Jan; 2(1):e115. PubMed ID: 18235846
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Solution structure of a conserved domain of antizyme: a protein regulator of polyamines.
    Hoffman DW; Carroll D; Martinez N; Hackert ML
    Biochemistry; 2005 Sep; 44(35):11777-85. PubMed ID: 16128579
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antizyme 3 inhibits polyamine uptake and ornithine decarboxylase (ODC) activity, but does not stimulate ODC degradation.
    Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
    Biochem J; 2009 Apr; 419(1):99-103, 1 p following 103. PubMed ID: 19076071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.